Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis.
糖尿病、降血糖藥物與癡呆風險:系統性綜述及統合分析。
Diabetes Obes Metab 2024-01-13
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.
SGLT2 抑制劑:通過對神經系統的多方面影響治療認知障礙的新療法。
Transl Neurodegener 2024-08-09
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review.
胰島素抗性作為精神分裂症認知功能障礙的可調整途徑:系統性回顧。
Schizophr Res 2024-09-12
From Glucose to Neuroprotection: Exploring Antidiabetic Medications as a Novel Approach to Alzheimer's Disease Treatment.
從葡萄糖到神經保護:探索抗糖尿病藥物作為阿茲海默症治療的新方法。
Cureus 2024-11-04
The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes.
葡萄糖代謝的雙重生活:腦部健康、血糖穩態與您的2型糖尿病患者。
BMC Med 2024-12-19
Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight.
DPP-4 或 SGLT2 抑制劑對於接受美克洛芬治療的 2 型糖尿病患者輕度認知障礙的正面影響:一項代謝組學的機制洞察。
Biomed Pharmacother 2024-12-22
The Promising Potency of Sodium-Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients.
鈉-葡萄糖共轉運蛋白 2 抑制劑在預防及治療 2 型糖尿病患者認知障礙中的潛在效能。
Biomedicines 2025-01-08
Cognitive dysfunction in diabetes - the 'forgotten' diabetes complication: a narrative review.
糖尿病中的認知功能障礙 - 被「遺忘」的糖尿病併發症:一篇敘述性回顧。
Scand J Prim Health Care 2025-01-29
Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis.
糖尿病藥物對於發展癡呆、輕度認知障礙或認知衰退風險的影響:系統性回顧與統合分析。
J Alzheimers Dis 2025-02-28